Chemours Company (NYSE:CC) shares, rose in value, with the stock price down by -5.74% to the previous day’s close as strong demand from buyers drove the stock to $10.01.
Actively observing the price movement in the last trading, the stock closed the session at $10.62. The PE ratio was 48.64 over 12-month period. Referring to stock’s 52-week performance, its high was $26.98, and the low was $9.33. On the whole, CC has fluctuated by -18.88% over the past month.
With the market capitalization of Chemours Company currently standing at about $1.50 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 0.84, with its dividend yield at 8.37%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CC’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 1.42, with the price of CC currently trading nearly -11.63% and -16.68% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 36.22, while the 7-day volatility ratio is showing 4.94% which for the 30-day chart, stands at 4.11%. Furthermore, Chemours Company (CC)’s beta value is 1.63, and its average true range (ATR) is 0.61.
A comparison of Chemours Company (CC) with its peers suggests the former has fared considerably weaker in the market. CC showed an intraday change of -5.74% in last session, and over the past year, it shrunk by -62.93%%.
Data on historical trading for Chemours Company (NYSE:CC) indicates that the trading volumes over the past 3 months, they’ve averaged 3.70 million. According to company’s latest data on outstanding shares, there are 149.57 million shares outstanding.
Nearly 0.74% of Chemours Company’s shares belong to company insiders and institutional investors own 93.66% of the company’s shares. The stock has fallen by -40.77% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CC stock heading into the next quarter.
